Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab (PDS) Adrian Fung (Australia)
Faricimab in Neovascular Age-Related Macular Degeneration: 48-Week Results by Dosing Cohort in the Phase 3 TENAYA/LUCERNE Trials Stephan Michels (Switzerland)
Brolucizumab for the Treatment of Diabetic Macular Edema: 52-week Results from the KINGFISHER Study Andres Emanuelli (Puerto Rico)
Efficacy and safety of biosimilar QL1207 vs aflibercept for neovascular age-related macular degeneration (nAMD): a phase 3 trial TBA
Real World Efficacy, Durability and Safety of Faricimab in Diabetic Macular Edema: The TAHOE Study Tyler Ewing (United States)
Eight-year visual acuity outcomes of the Treat-and-Extend Regimen in Management of Neovascular Age-related Macular Degeneration Rodney Fong (United States)
Safety and Efficacy of Intravitreal Conbercept in China: A Long-term, Prospective, Multi-center and Real-World Study (STONE STUDY) Xinyuan Zhang (People's Republic of China)
